SCHEMBL8766893

SCHEMBL8766893

CCC(C(=O)c1ccc(OCCCCCCCCCl)cc1)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 7/20 0.58
HSD17B10 Q99714 1/20 0.58
SMN1; SMN2 Q16637 7/20 0.55
TP53 P04637 3/20 0.55
MAPT P10636 2/20 0.55
MEN1 O00255 1/20 0.55
THRB P10828 1/20 0.55
KMT2A Q03164 1/20 0.55
MITF O75030 1/20 0.54
RAB9A P51151 1/20 0.54
NLRP1 Q9C000 1/20 0.54
JAK2 O60674 2/20 0.52
TSHR P16473 2/20 0.49
GAA P10253 2/20 0.48
PLA2G4B P0C869 2/20 0.48
PAX8 Q06710 1/20 0.47
ALDH1A1 P00352 2/20 0.47
MMP9 P14780 1/20 0.46
MMP8 P22894 1/20 0.46
MMP13 P45452 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10828017 1.00 LMNA (0.58) LMNAHSD17B10SMN1; SMN2TP53MAPT
SCHEMBL8645421 1.00 LMNA (0.58) LMNAHSD17B10SMN1; SMN2TP53MAPT
SCHEMBL8767682 0.99 LMNA (0.59) LMNAHSD17B10SMN1; SMN2TP53MAPT
SCHEMBL8766911 0.95 LMNA (0.61) LMNAHSD17B10SMN1; SMN2TP53MAPT
SCHEMBL845072 0.92 LMNA (0.61) LMNAHSD17B10SMN1; SMN2TP53MAPT
SCHEMBL8656435 0.89 LMNA (0.57) LMNAHSD17B10SMN1; SMN2TP53MAPT
SCHEMBL10827626 0.86 BCHE (0.57) LMNAHSD17B10SMN1; SMN2TP53MAPT
SCHEMBL10827976 0.86 BCHE (0.57) LMNAHSD17B10SMN1; SMN2TP53MAPT
SCHEMBL11500794 0.85 LMNA (0.62) LMNAHSD17B10SMN1; SMN2TP53MAPT
SCHEMBL10827790 0.85 BCHE (0.56) LMNAHSD17B10SMN1; SMN2TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0638064-B1 SUBSTITUTED 1,1,2-TRIPHENYLBUTENES AND THEIR USE IN THE TREATMENT AND DIAGNOSIS OF CANCER BRITISH TECH GROUP (GB) 1997-08-13 EP disclosed
US-5589500-A TREATMENT OF TUMORS OR ANTICARCINOGENIC AGENTS BRITISH TECHNOLOGY GROUP LIMITED (GB) 1996-12-31 US disclosed
EP-0638064-A1 SUBSTITUTED 1,1,2-TRIPHENYLBUTENES AND THEIR USE IN THE TREATMENT AND DIAGNOSIS OF CANCER. BRITISH TECH GROUP (GB) 1995-02-15 EP disclosed
WO-1993022275-A1 SUBSTITUTED 1,1,2-TRIPHENYLBUTENES AND THEIR USE IN THE TREATMENT AND DIAGNOSIS OF CANCER BRITISH TECHNOLOGY GROUP LTD (GB) 1993-11-11 WO disclosed